PharmaBoardroom

Oh Pil-Soo, managing director of Lundbeck Korea, talks about the challenges of pricing and reimbursement in the CNS area and remaining committed to…

Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded…

Cho Chan-Hwui, president of the Korean Pharmaceutical Association (KPA), discusses the major hurdles that pharmacists in Korea must overcome today,…

The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an…

The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an…

Glenmark's country manager for Argentina discusses Argentina’s development expertise and how companies like Glenmark can capitalize on it through…

President of the company, Alberto Alvarez-Saavedra, discusses the company’s transformation into a professional organization, and the strategy which…

“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia's president and managing…

“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia's president and managing…

“Clinical trials are an area where we want to build capabilities, both internally and externally” says Novartis Malaysia's president and managing…

Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing…

The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated…